Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST) (PAZOGIST)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01323400 |
Recruitment Status :
Completed
First Posted : March 25, 2011
Last Update Posted : February 25, 2016
|
Sponsor:
Centre Leon Berard
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Centre Leon Berard
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | April 2014 |
Actual Study Completion Date : | February 2016 |
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):